MUMBAI: Shares of Cipla plunged 7% on Monday and hit their lowest level in about 7 months as observations issued by the US Food and Drug Administration (US FDA) to the company’s Pithampur manufacturing facility in Madhya Pradesh raised concerns over earnings. The stock hit a 7-month low of Rs 955.25 on the National Stock … Read more
Brokerage firm Jefferies maintained a buy rating on , Morgan Stanley has an overweight rating on Dr Reddy’s Laboratories, Nomura maintained a buy on , and Nirmal Bang has a buy rating on post Q3 results. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Jefferies on Bajaj … Read more
Brokerages maintained their rating on post its June quarter results despite a marginal drop in net profit on a strong product pipeline and demand recovery. Shares of Cipla rallied more than 4 per cent in intraday trade on Monday to reclaim Rs 1,000 levels. Long-term investors can look to buy the stock now or on … Read more